Proteínas Quinasas y Oncología Molecular

Publicaciones

  • 15/03/2025

    Journal of mammary gland biology and neoplasia

    Buenos Aires Breast Cancer Symposium (BA-BCS 2024) A Second Successful «Trial» for Bringing Together both World Hemispheres To Debate the Future of Translational Breast Cancer Research

    Claudia Lanari, Virginia Novaro, Mario Rossi, Edith C Kordon

  • 24/10/2024

    Scientific reports

    Higher risk of recurrence in early-stage breast cancer patients with increased levels of ribosomal protein S6

    Florencia Cascardo, Micaela Vivanco, María Cecilia Perrone, Andrea Werbach, Diego Enrico, Pablo Mando, Mora Amat, Paula Martínez-Vazquez, Javier Burruchaga, María Mac Donnell, Claudia Lanari, Ariel Zwenger, Federico Waisberg, Virginia Novaro

  • 19/10/2024

    Interdisciplinary Cancer Research

    Tumor Heterogeneity in Triple-Negative Breast Cancer: Shedding Light on the Role of AKT and RUNX

    Antonella S. Vila, Natalia B. Fernández, Florencia L. Cascardo, Gonzalo M. Sánchez, Virginia Novaro, Natalia Rubinstein, Matías Blaustein

  • 25/11/2023

    International journal of molecular sciences

    miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome

    Juana Moro, Agustina Grinpelc, Paula Lucía Farré, Rocío Belén Duca, Ezequiel Lacunza, Karen Daniela Graña, Georgina Daniela Scalise, Guillermo Nicolás Dalton, Cintia Massillo, Flavia Piccioni, Federico Dimase, Emilio Batagelj, Adriana De Siervi, Paola De Luca

  • 01/06/2023

    Life sciences

    CDK4/6 are necessary for UCP1-mediated thermogenesis of white adipose tissue

    Andrea Estefanía Portales, Ignacio Miguel, María Jimena Rodriguez, Virginia Novaro, Sabrina Eliana Gambaro, Andrés Giovambattista

  • 01/03/2023

    Clinical Cancer Research

    Beneficial effects of mifepristone treatment in breast cancer patients selected by the progesterone receptor isoform ratio: Results from the MIPRA trial

    Andrés Elía, Leo Saldain, Silvia I Vanzulli, Luisa A Helguero, Caroline A Lamb, Victoria Fabris, Gabriela Pataccini, Paula Martínez-Vazquez, Javier Burruchaga, Ines Caillet-Bois, Eunice Spengler, Gabriela Acosta Haab, Marcos Liguori, Alejandra Castets, Silvia Lovisi, María F Abascal, Virginia Novaro, Jana Sánchez, Javier Muñoz, Jose M Belizán, Martín C Abba, Hugo Gass, Paola Rojas, Claudia Lanari

  • 15/02/2023

    Scientific reports

    Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models

    María Jimena Rodriguez, María Cecilia Perrone, Marina Riggio, Marta Palafox, Valeria Salinas, Andrés Elia, Natali Daiana Salgueiro, Andrea Eugenia Werbach, María Paula Marks, Marcelo A Kauffman, Luciano Vellón, Violeta Serra, Virginia Novaro

  • Frontiers in Oncology

    26/10/2022

    Frontiers in Oncology

    Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients

    Rocío Belén Duca, Cintia Massillo, Paula Lucía Farré, Karen Daniela Graña, Juana Moro, Kevin Gardner, Ezequiel Lacunza, Adriana De Siervi

  • 08/07/2022

    JCI insight

    Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race

    Sandeep K Singhal, Jung S Byun, Tingfen Yan, Ryan Yancey, Ambar Caban, Sara Gil Hernandez, Sediqua Bufford, Stephen M Hewitt, Joy Winfield, Jaya Pradhan, Vesco Mustkov, Jasmine A McDonald, Eliseo J Pérez-Stable, Anna María Nápoles, Nasreen Vohra, Adriana De Siervi, Clayton Yates, Melissa B Davis, Mei Yang, Yien Che Tsai, Allan M Weissman, Kevin Gardner

  • Cells

    15/10/2021

    International Journal of Molecular Sciences

    MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis

    Paula Lucía Farré, Rocío Belén Duca, Cintia Massillo, Guillermo Nicolás Dalton, Karen Daniela Graña, Kevin Gardner, Ezequiel Lacunza, Adriana De Siervi